Editorial: It’s cheaper to fly to India than treat Hep C in NM

New Mexicans spent $36.5 million last year treating a fraction of the state’s Medicaid hepatitis C patients, and a good portion of that was for a prescription medication that cures the liver-wasting disease. State taxpayers are on pace to make that price tag look like a deal this year, spending $17 million in the first quarter alone to treat just 301 patients. When a 12-week course of the drug Harvoni, made by California drugmaker Gilead Sciences, costs $

Decisive Action Needed to Increase Patient Access to Hepatitis C Treatment

"Pharmaceutical pricing for HCV is unconscionable," Dr. Edlin said. "They are extortionist prices because the choice is really your money or your life. And the restrictions payers have imposed defy medical guidelines, lack scientific justification, and undermine public health efforts to stem transmission and end the epidemic." Despite the approval of effective hepatitis C virus (HCV) treatment regimens, the exceedingly high cost of the medication prevents...